In this commentary, Michael J. Bloch, MD, writes about the epidemiological link between influenza infection and cardiovascular events and the potential benefits of influenza vaccination on cardiovascular...
In this article, James Matera, DO, FACOI, reviews the case presentation of a patient with chronic kidney disease (CKD) and provides guidance on diagnosing, treating, and managing CKD, and also discusses...
In this commentary, John W. Harrington, MD, writes about the struggles faced by some young adults with autism when finding employment and staying employed, managing work-related stress, and misinterpreting...
In this commentary, John W. Harrington, MD, writes about the struggles faced by some young adults with autism when finding employment and staying employed, managing work-related stress, and misinterpreting...
In this commentary, John W. Harrington, MD, writes about the struggles faced by some young adults with autism when finding employment and staying employed, managing work-related stress, and misinterpreting...
In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this article, James Matera, DO, writes about a newer agent, finarenone, which is a nonsteroidal, selective mineralocorticoid receptor antagonist that can treat chronic kidney disease.
In this article, James Matera, DO, writes about a newer agent, finarenone, which is a nonsteroidal, selective mineralocorticoid receptor antagonist that can treat chronic kidney disease.
